Medication Need - Trikafta

The New York Office of Children and Family Services (OCFS) is seeking to procure the specialty medication Trikafta through a single-source, sole-source procurement for an at-risk youth in custody located in Tioga County. The primary objective of this contract opportunity is to obtain the medication to treat Cystic Fibrosis, with a specific focus on addressing the genetic mutation causing the disease. Trikafta, recognized as a breakthrough medication, not only improves symptoms but also slows disease progression, enabling patients to live longer and participate more fully in life. The procurement is unique in that the medication can only be filled by a specialty pharmacy, with Caremark, LLC identified as the sole award recipient. The contract opportunity was posted on June 24, 2025, with an advertisement end date of July 1, 2025, and is specifically targeted at addressing the medical needs of a youth in OCFS custody.

While the contract opportunity does not explicitly outline set-aside designations or specific restrictions on responding organizations, it is a specialized procurement focused on a specific medical need through a single-source vendor. Caremark, LLC is designated as the exclusive vendor for this medication procurement, effectively limiting competitive bidding. The procurement appears to be targeted specifically at providing essential medical treatment for an individual youth in the custody of OCFS, with the medication being a critical intervention for managing Cystic Fibrosis. No specific budget range or award value is provided in the documentation, though the focus is clearly on meeting a specific, targeted medical requirement. The procurement is geographically centered in Tioga County, New York, and represents a direct medical intervention strategy for an at-risk youth under state care.